Discover 2,726 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,726
Active & Responsive
An Innovative Master Platform for Clinical Trials in Mood Disorders
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
for
Post Procedural Erythema
Location: Manhattan NY, Syosset NY, New York NY, Montreal,
Sponsor: Acorn Biolabs Inc.
Sex: All
Age: 18+
Code: NCT06477172
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Fredericton, Boston MA, Cromwell CT, Quebec,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase 2, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Boston MA, East Greenwich RI, Hamden CT, Sherbrooke,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase 2, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight